AbbVie joins US government pilot to test drug discount rebates
US drugmaker AbbVie NYSE:ABBV said on Friday it would participate in a US government pilot program aimed at testing a new rebate system for discounted medicines.Here are some details
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
US drugmaker AbbVie NYSE:ABBV said on Friday it would participate in a US government pilot program aimed at testing a new rebate system for discounted medicines.Here are some details